heart attacks claim the lives of many people each year. Poor food and lifestyle choices are the main cause of this. Nevertheless, a low-cost and efficient method of avoiding this has also been found. Although heart attacks can happen at any time, they can be prevented by taking preventative measures.
According to a recent study, there is a low-cost and efficient method of preventing heart attacks, particularly for people who have already experienced one. According to this study, ezetimibe and statins, two inexpensive medications, can greatly lower the chance of having a heart attack and prevent one from happening again.
What does the research say?
After analyzing data from over 36,000 cardiac patients, researchers from Lund university in sweden and Imperial college in london discovered that these medications can be quite successful at preventing heart attacks if taken on schedule. Most importantly, the risk of heart attacks can be considerably decreased by controlling cholesterol beforehand.
Why Early treatment is important?
The body enters a sensitive state following a heart attack, where the arteries weaken and the chance of having another heart attack rises. Nevertheless, many individuals do not receive cholesterol-lowering medications right away. The doctors' current approach is "wait and watch," wherein one medication is administered first, followed by additional medications based on need; however, delaying medication can have negative consequences.
Combination of statins and ezetimibe
Heart disease is already treated with statins. They lower the liver's cholesterol levels, particularly the harmful LDL cholesterol. Conversely, ezetimibe prevents the intestines from absorbing cholesterol. Together, the two medications efficiently and rapidly lower cholesterol.
What was found in this study?
Researchers from sweden and the UK examined heart attack survivors in their study. Three groups—those taking ezetimibe later, those using statins alone, and those taking both medications within 12 weeks of the heart attack—were compared. According to the findings, patients who started the combination medication early had a lower death rate, a lower chance of having another heart attack, and fewer heart issues down the road.
Affordable and available medicines
The study also found that both of these drugs are already available in most countries and are not expensive. Ezetimibe is cheaper and has fewer side effects. Yet it is often overlooked in initial treatment.
According to a recent study, there is a low-cost and efficient method of preventing heart attacks, particularly for people who have already experienced one. According to this study, ezetimibe and statins, two inexpensive medications, can greatly lower the chance of having a heart attack and prevent one from happening again.
What does the research say?
After analyzing data from over 36,000 cardiac patients, researchers from Lund university in sweden and Imperial college in london discovered that these medications can be quite successful at preventing heart attacks if taken on schedule. Most importantly, the risk of heart attacks can be considerably decreased by controlling cholesterol beforehand.
Why Early treatment is important?
The body enters a sensitive state following a heart attack, where the arteries weaken and the chance of having another heart attack rises. Nevertheless, many individuals do not receive cholesterol-lowering medications right away. The doctors' current approach is "wait and watch," wherein one medication is administered first, followed by additional medications based on need; however, delaying medication can have negative consequences.
Combination of statins and ezetimibe
Heart disease is already treated with statins. They lower the liver's cholesterol levels, particularly the harmful LDL cholesterol. Conversely, ezetimibe prevents the intestines from absorbing cholesterol. Together, the two medications efficiently and rapidly lower cholesterol.
What was found in this study?
Researchers from sweden and the UK examined heart attack survivors in their study. Three groups—those taking ezetimibe later, those using statins alone, and those taking both medications within 12 weeks of the heart attack—were compared. According to the findings, patients who started the combination medication early had a lower death rate, a lower chance of having another heart attack, and fewer heart issues down the road.
Affordable and available medicines
The study also found that both of these drugs are already available in most countries and are not expensive. Ezetimibe is cheaper and has fewer side effects. Yet it is often overlooked in initial treatment.
click and follow Indiaherald WhatsApp channel